mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.4 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.06 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
7e-08 |